PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Clinical trial NCT07007117 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07007117
Sponsor: Stephan Grupp MD PhD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Neuroblastoma Relapsed Neuroblastoma High-Risk Neuroblastoma

Start date: 2025-06-20
Primary completion: 2032-06-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.